# Extracorporeal Blood Purification as a Treatment Modality for COVID-19

> **NCT04478539** · — · COMPLETED · sponsor: **Zan Mitrev Clinic** · enrollment: 35 (actual)

## Conditions studied

- Covid19

## Interventions

- **DEVICE:** Extracorporeal blood purification using the oXiris® (AN69ST) hemofilter

## Key facts

- **NCT ID:** NCT04478539
- **Lead sponsor:** Zan Mitrev Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-01
- **Primary completion:** 2021-07-01
- **Final completion:** 2021-07-01
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2022-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04478539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04478539, "Extracorporeal Blood Purification as a Treatment Modality for COVID-19". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT04478539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*